Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor
Crossref DOI link: https://doi.org/10.1007/s12185-016-2074-3
Published Online: 2016-08-04
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uemura, Makiko
Imataki, Osamu
Kawachi, Yasunori
Kawakami, Kimihiro
Hoshijima, Yasuo
Matsuoka, Akihito
Kadowaki, Norimitsu
License valid from 2016-08-04